These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18080768)

  • 21. Multidimensional Impact of Mediterranean Diet on IBD Patients.
    Chicco F; Magrì S; Cingolani A; Paduano D; Pesenti M; Zara F; Tumbarello F; Urru E; Melis A; Casula L; Fantini MC; Usai P
    Inflamm Bowel Dis; 2021 Jan; 27(1):1-9. PubMed ID: 32440680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum ST2 in inflammatory bowel disease: a potential biomarker for disease activity.
    Boga S; Alkim H; Koksal AR; Ozagari AA; Bayram M; Tekin Neijmann S; Sen I; Alkim C
    J Investig Med; 2016 Jun; 64(5):1016-24. PubMed ID: 27001944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased circulating circular RNA_103516 is a novel biomarker for inflammatory bowel disease in adult patients.
    Ye YL; Yin J; Hu T; Zhang LP; Wu LY; Pang Z
    World J Gastroenterol; 2019 Nov; 25(41):6273-6288. PubMed ID: 31749597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granulocytapheresis in steroid-dependent and steroid-resistant patients with inflammatory bowel disease: a prospective observational study.
    Sacco R; Romano A; Mazzoni A; Bertini M; Federici G; Metrangolo S; Parisi G; Nencini C; Giampietro C; Bertoni M; Tumino E; Scatena F; Bresci G
    J Crohns Colitis; 2013 Dec; 7(12):e692-7. PubMed ID: 23870727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Increased Serum N-Terminal Telopeptide of Type I Collagen, a Biochemical Marker of Increased Bone Resorption, Is Associated with Infliximab Therapy in Patients with Crohn's Disease.
    Sugimoto K; Ikeya K; Iida T; Kawasaki S; Arai O; Umehara K; Watanabe F; Tani S; Oishi S; Osawa S; Yamamoto T; Hanai H
    Dig Dis Sci; 2016 Jan; 61(1):99-106. PubMed ID: 26254083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased levels of serum omentin-1 in patients with inflammatory bowel disease.
    Yin J; Hou P; Wu Z; Nie Y
    Med Sci Monit; 2015 Jan; 21():118-22. PubMed ID: 25576244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum galectins as potential biomarkers of inflammatory bowel diseases.
    Yu TB; Dodd S; Yu LG; Subramanian S
    PLoS One; 2020; 15(1):e0227306. PubMed ID: 31929564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum Dipeptidyl Peptidase 4: A Predictor of Disease Activity and Prognosis in Inflammatory Bowel Disease.
    Pinto-Lopes P; Afonso J; Pinto-Lopes R; Rocha C; Lago P; Gonçalves R; Tavares De Sousa H; Macedo G; Camila Dias C; Magro F
    Inflamm Bowel Dis; 2020 Oct; 26(11):1707-1719. PubMed ID: 31912883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between Serological Biomarkers and Disease Activity in Patients with Inflammatory Bowel Disease.
    Xu M; Cen M; Chen X; Chen H; Liu X; Cao Q
    Biomed Res Int; 2019; 2019():6517549. PubMed ID: 31950048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease.
    Yoshimura T; Mitsuyama K; Sakemi R; Takedatsu H; Yoshioka S; Kuwaki K; Mori A; Fukunaga S; Araki T; Morita M; Tsuruta K; Yamasaki H; Torimura T
    Mediators Inflamm; 2021; 2021():8825374. PubMed ID: 33623482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of serum-soluble triggering receptor expressed on myeloid cells-1 with clinical disease activity in inflammatory bowel disease.
    Park JJ; Cheon JH; Kim BY; Kim DH; Kim ES; Kim TI; Lee KR; Kim WH
    Dig Dis Sci; 2009 Jul; 54(7):1525-31. PubMed ID: 18975078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum vitamin D but not zinc levels are associated with different disease activity status in patients with inflammatory bowel disease.
    Mechie NC; Mavropoulou E; Ellenrieder V; Petzold G; Kunsch S; Neesse A; Amanzada A
    Medicine (Baltimore); 2019 Apr; 98(15):e15172. PubMed ID: 30985701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.
    Chang J; Leong RW; Wasinger VC; Ip M; Yang M; Phan TG
    Gastroenterology; 2017 Sep; 153(3):723-731.e1. PubMed ID: 28601482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired erythrocyte antioxidant defense in active inflammatory bowel disease: impact of anemia and treatment.
    Krzystek-Korpacka M; Neubauer K; Berdowska I; Zielinski B; Paradowski L; Gamian A
    Inflamm Bowel Dis; 2010 Sep; 16(9):1467-75. PubMed ID: 20186929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effect of anti-TNFα Induction Therapy on the Nutritional Status and Dietary Intake in Inflammatory Bowel Disease.
    Csontos ÁA; Molnár A; Piri Z; Katona B; Dakó S; Pálfi E; Miheller P
    J Gastrointestin Liver Dis; 2016 Mar; 25(1):49-56. PubMed ID: 27014753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infliximab trough levels are decreasing over time in patients with inflammatory bowel disease on maintenance treatment with infliximab.
    Orfanoudaki E; Gazouli M; Foteinogiannopoulou K; Theodoraki E; Legaki E; Romanos I; Mouzas I; Koutroubakis IE
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):187-191. PubMed ID: 30543573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth differentiation factor-15 serum concentrations reflect disease severity and anemia in patients with inflammatory bowel disease.
    Tonkic A; Kumric M; Akrapovic Olic I; Rusic D; Zivkovic PM; Supe Domic D; Sundov Z; Males I; Bozic J
    World J Gastroenterol; 2024 Apr; 30(13):1899-1910. PubMed ID: 38659482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
    Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
    World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced serum insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 levels in adults with inflammatory bowel disease.
    Katsanos KH; Tsatsoulis A; Christodoulou D; Challa A; Katsaraki A; Tsianos EV
    Growth Horm IGF Res; 2001 Dec; 11(6):364-7. PubMed ID: 11914023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.
    Ardizzone S; Bollani S; Bettica P; Bevilacqua M; Molteni P; Bianchi Porro G
    J Intern Med; 2000 Jan; 247(1):63-70. PubMed ID: 10672132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.